Christiane P.
- Country
- Germany
- Department
- Klinik und Poliklinik für Dermatologie und Allergologie
Research Overview
- A Phase II, randomised, placebo-controlled, double-blind, parallel-group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with progressive systemic sclerosis
- Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: An Open-label Extension Study
- Efficacy and Safety Evaluation of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 27 of 106 partner sites.
Specializations
Dermatology and Inflammatory Skin Disease
Clinical research activity includes psoriasis, hidradenitis suppurativa, atopic dermatitis, bullous pemphigoid, generalized pustular psoriasis, prurigo nodularis, and cutaneous lupus erythematosus, with additional interest in chronic ulcerative skin conditions.
- Psoriasis
- Hidradenitis suppurativa
- Bullous pemphigoid
- Cutaneous lupus erythematosus
The therapeutic focus extends to immune-mediated skin disorders requiring targeted anti-inflammatory and immunomodulatory treatment.
Gastroenterology and Inflammatory Bowel Disease
Research involvement spans Crohn’s disease, ulcerative colitis, pediatric inflammatory bowel disease, and related intestinal immune disorders, including studies in refractory disease settings.
- Crohn’s disease
- Ulcerative colitis
- Inflammatory bowel disease
- Chronic intestinal inflammation
Therapeutic interests include biologic and advanced immune-directed approaches for gastrointestinal inflammation and mucosal disease control.
Melanoma and Other Skin Cancers
Clinical trial activity includes melanoma, advanced cutaneous squamous cell carcinoma, and other skin cancers, with emphasis on recurrent, metastatic, and resected disease contexts.
- Melanoma
- Cutaneous squamous cell carcinoma
- Advanced skin cancer
- Resected high-risk melanoma
The therapeutic landscape includes immunotherapy and perioperative treatment strategies aimed at improving disease control in malignant skin tumors.
Rare Autoimmune and Connective Tissue Diseases
Research interests cover systemic sclerosis, IgG4-related disease, Sjögren’s disease, lupus nephritis, and other immune-mediated systemic disorders.
- Systemic sclerosis
- IgG4-related disease
- Sjögren’s disease
- Lupus nephritis
The therapeutic emphasis is on targeted immunologic treatment for chronic systemic inflammation and organ involvement.
Chronic Wound and Vascular Skin Complications
Investigator involvement also includes chronic venous ulcers, ulcerative pyoderma gangrenosum, and other difficult-to-heal inflammatory skin lesions linked to vascular and immune dysfunction.
- Chronic venous ulcers
- Pyoderma gangrenosum
- Chronic wound healing
- Inflammatory ulcerative skin disease
Therapeutic activity is centered on improving wound closure and controlling persistent cutaneous inflammation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.